Collagen Matrix, Inc., a leader in the design and engineering of collagen-based extracellular matrices for tissue and organ repair and regeneration, has received USFDA 510(k) clearance of its Collagen Nerve Wrap indicated for the management of peripheral nerve injuries in which there has been no substantial loss of nerve tissue and where gap closure can be achieved by flexion of the extremity.

Collagen Nerve Wrap, a resorbable collagen matrix that provides a non-constricting encasement for injured peripheral nerves for protection of the neural environment, is designed to be an interface between the nerve and the surrounding tissue.

Upon hydration, Collagen Nerve Wrap is an easy to handle, soft, pliable, nonfriable, porous collagen matrix. This product's proprietary design allows Collagen Nerve Wrap to be spread open for easy placement over the injured nerve and to maintain closure without sutures.

"As we continue our advanced research and development in the area of peripheral nerve repair under the NIH-funded bioactive nerve guide project for long gap nerve injuries, the Collagen Nerve Wrap product line addresses an immediate clinical need in the area of crush injuries or short gap nerve injuries.

This regulatory clearance further demonstrates our commitment to the area of peripheral nerve repair," said Shu-Tung Li, Ph.D., Founder and CEO of Collagen Matrix.

Collagen Nerve Wrap is available as sterile, non-pyrogenic, for single use only, in a variety of sizes, in double peel packages.

Read more at PR Newswire.